Trusted Professional

SEC Charges President of Biotech Firm for COVID-19 Testing Investment Scam

The Securities and Exchange Commission

"We allege that Mark Schena took advantage of the COVID-19 pandemic at the expense of investors," said Erin E. Schneider, Director of the SEC's San Francisco Regional Office. "A pandemic does not exempt public company executives from their responsibility to make accurate disclosures."

Want to learn more about scams and fraudulent activity? Attend the Fraud Update: Detecting and Preventing the Top Ten Fraud Schemes Seminar Webcast.